HANH-TIEN TRAN: Open Payments
NPI 1063548873 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$330 in 14 payments from 7 companies in 2025. Trend: 2023 $783 · 2024 $549 · 2025 $330
Food & beverage: $330
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $115 |
| Novo Nordisk Inc | 3 | $75 |
| Lilly USA, LLC | 2 | $39 |
| Astellas Pharma US Inc | 1 | $32 |
| Optinose US, Inc. | 1 | $28 |
| Exact Sciences Corporation | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: QULIPTA, Ozempic, Veozah, UBRELVY, Xhance, Wegovy, The Cologuard Plus Collection Kit, REXULTI.
Industry payments across VA — which companies pay providers there.
